| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on CSL LIMITED |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
|
AstraZeneca shares fall on 'hefty' $39-billion Alexion deal |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
14 |
| Average target price |
229,27 $ |
| Last Close Price |
205,85 $ |
| Spread / Highest target |
22,0% |
| Spread / Average Target |
11,4% |
| Spread / Lowest Target |
-5,20% |
Consensus revision (last 18 months)
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
